Gaithersburg-based MedImmune, which is gaining hundreds of jobs in a consolidation by parent company AstraZeneca PLC, has completed its acquisition of AlphaCore Pharma LLC for an undisclosed sum.
The Ann Arbor, Mich.-based biotechnology company is developing a drug for high cholesterol. Cardiovascular and metabolic disease is one of MedImmune’s core research areas.
{iframe}http://www.bizjournals.com/washington/news/2013/04/03/medimmune-acquires-alphacore-pharma.html{/iframe}